|

ANIKA THERAPEUTICS INC (ANIK)

US0352551081 - Common Stock

22.66  +0.75 (+3.42%)

After market: 22.66 0 (0%)

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
163.31M156.20M147.80M130.50M114.60M
Cost Of Goods
62.42M62.70M64.90M61.40M28.70M
Gross Profit
100.88M93.60M82.90M69.00M85.90M
Operating Expenses
125.14M112.90M80.30M54.90M51.70M
Research and Development
32.85M28.20M27.30M23.40M16.70M
Selling, General, and Administrative Expenses
92.29M84.80M74.10M60.10M35.00M
Operating Income
-24.24M-19.40M2.60M14.20M34.20M
Interest Income/Expense
2.02M700.00K-200.00K-300.00K1.90M
Non Recurring Items
-6.28M0.000.00-42.50MN/A
Income Before Taxes
-28.51M-18.70M2.40M-28.60M36.10M
Income Tax
-3.93M-3.90M-1.70M-4.60M8.90M
Net Income
-24.58M-14.90M4.10M-24.00M27.20M
EBITDA
-9.93M-4.92M16.92M27.66M40.19M
 
Per Share Data
EPS Diluted Total Ops
-1.69-1.020.28-1.691.89
Non GAAP EPS
-1.45-0.890.29-0.642.06
 
Statistics
Gross Profit Margin
61.77%59.92%56.09%52.87%74.96%
Profit Margin
-15.05%-9.54%2.77%-18.39%23.73%
Operating Profit Margin
-14.84%-12.42%1.76%10.88%29.84%

All data in USD

Charts